FDA Approval of Breakthrough Neuroimmune Modulation System for Rheumatoid Arthritis

August 20, 2025

SetPoint Medical has recently obtained FDA approval for an implanted, rechargeable neurostimulator and its accompanying neck-worn wireless charger. The IT’IS Customized Research Team supported this effort ensuring dosimetric compliance. The system delivers electrical pulses to help reduce inflammation in patients with rheumatoid arthritis.